ArticlePloS one2025
The effects of physical activity and platelet-high-density lipoprotein cholesterol ratio on the risk of anxiety disorders: A cross-sectional study based on NHANES 2015-2023.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anxiety disorders are a global mental health issue that is strongly associated with lifestyle factors. Physical activity (PA) could benefit anxiety symptoms, though the precise effect remains controversial. The platelet-to-high-density lipoprotein cholesterol (HDL-C) ratio (PHR) is an emerging biomarker and has gained attention for its link to mental health. This study used data from the 2015-2023 National Health and Nutrition Examination Survey (NHANES) to examine the effects of PA and PHR on the risk of anxiety disorders. NHANES 2015-2023 data were used to examine participants' PA, PHR, and their relationship to anxiety symptoms using a cross-sectional design. Moreover, logistic regression, subgroup, and unrestricted cubic spline analyses were employed in this study. The analysis results indicated that higher intensity PA significantly reduced the risk of anxiety disorders (OR = 0.824, 95% CI: 0.716-0.948, p < 0.05). Both moderate PHR (OR = 0.769, 95% CI: 0.664-0.891, p < 0.001) and higher PHR (OR = 0.781, 95% CI: 0.670-0.911, p < 0.05) were significantly associated with reduced anxiety risk compared to the lowest quartile of PHR. A non-linear relationship was observed, and the risk was reduced when PHR ranged between 4.51 and 10.18, and increased when PHR was outside this range. Subgroup analysis results revealed significant variations in effects across age, gender, lifestyle, and chronic disease groups. This study confirmed the significant role of PA and PHR in regulating anxiety disorder risk. Future interventions should tailor PA intensity and PHR levels to individual differences to improve the prevention and treatment of anxiety disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.